OS Therapies Incorporated financials
$1.61−2.42%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating income | -$8.6M | -$10.2M | -$12.0M | -$6.9M | -$4.8M | -$5.0M | -$3.0M | -$2.4M |
| Net income | -$8.6M | -$10.4M | -$13.5M | -$6.9M | -$4.5M | -$3.9M | -$3.0M | -$2.9M |
| Net margin | — | — | — | — | — | — | — | — |
| Diluted EPS | $-0.20 | $-0.27 | $-0.35 | $-0.21 | $-0.19 | $-0.18 | $-0.23 | $-0.18 |
| EBITDA | -$8.5M | -$10.0M | -$11.9M | -$6.8M | -$4.7M | -$5.0M | -$4.4M | -$2.1M |
| Operating cash flow | -$5.5M | -$4.6M | -$3.7M | -$4.7M | -$2.4M | -$3.4M | -$2.4M | -$3.4M |
| Free cash flow | -$5.5M | -$4.6M | -$3.7M | -$4.7M | -$2.7M | -$3.6M | -$2.4M | -$3.4M |
| Diluted shares | 43.9M | 38.7M | 38.7M | 32.0M | 25.1M | 21.2M | 21.6M | 15.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $205.0K | $917.6K | $269.8K | $1.9M | $2.8M | $3.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $100.0K | $1.4M | $100.0K | $100.0K | $100.0K | $100.0K |
| Total assets | $9.9M | $7.3M | $6.8M | $9.0M | $10.3M | $4.2M |
| Total liabilities | $20.7M | $17.1M | $11.9M | $4.2M | $3.6M | $3.6M |
| Shareholders' equity | -$11.9M | -$10.8M | -$6.1M | $3.6M | $4.9M | -$4.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology